Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,380 across all filing types
Latest filing 2017-07-14 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2017-07-14 English
THIRD ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Capital/Financing Update Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under the Hong Kong Stock Exchange rules. It informs creditors about the general mandate granted to the board to repurchase H shares and the process for creditors to claim their rights. The content focuses on procedural information related to creditor claims and share repurchase authorization, rather than financial results, management changes, or detailed financial data. It is not a full financial report, earnings release, or management discussion. The document is a regulatory announcement related to capital management and creditor notification, fitting best under the category of Capital/Financing Update (CAP). The document length is about 5,387 characters, which is sufficient for a substantive announcement rather than a brief notice. Therefore, the classification is CAP with high confidence.
2017-07-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2017-07-07 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2017 THIRD TRANCHE OF SUPER-SHORT-TERM BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the issuance of a tranche of super-short-term bonds by Yanzhou Coal Mining Company Limited. It provides details about the bond issuance such as amount, interest rate, term, and underwriters. The document is relatively short (3,258 characters) and serves as a formal announcement of a financing activity rather than a full financial report or detailed analysis. It does not contain comprehensive financial statements or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2017-07-06 English
Monthly Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/06/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and movements during the month, with no financial performance data, earnings, management discussion, or audit information. It is a regulatory disclosure about share capital movements rather than a financial report or earnings release. This type of document fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2017-07-03 English
OVERSEAS REGULATORY ANNOUNCEMENT - SECOND ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under the Hong Kong Stock Exchange rules. It relates to a general mandate granted to the board to repurchase H shares and informs creditors about their rights to claim against the company in relation to this repurchase. The document is titled as an "Overseas Regulatory Announcement" and is primarily a notification to creditors about the repurchase mandate and the process for claiming creditor rights. It does not contain financial statements, audit results, or detailed financial data. It is not a report itself but an announcement related to a corporate action (share repurchase mandate) and creditor notification. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2017-06-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.